1. Home
  2. Detail

@karolinesm: Neymar enfrentou dificuldades desde a infância, cresceu em uma família simples e precisou superar muitos obstáculos até realizar o sonho de se tornar jogador de futebol. Cada conquista foi construída com muito esforço e dedicação. Nas Copas do Mundo, viveu momentos de alegria, pressão, lesões e grandes desafios, sempre carregando a responsabilidade de representar milhões de brasileiros.Por trás do craque existe uma história de superação que inspira dentro e fora dos gramados. #futebol #futebolbrasileiro #copadomundo #neymar #pravoce

CURIOSIDADE SEM FIM
CURIOSIDADE SEM FIM
Open In TikTok:
Region: BR
Sunday 05 July 2026 15:05:43 GMT
2102
86
1
2

Music

Download

No Watermark .mp4 (2.5MB) No Watermark(HD) .mp4 (5.59MB) Watermark .mp4 (0MB) Music .mp3

Comments

rafaela.rocha.da
Rafaela Rocha Da Silva Rocha :
vencedor
2026-07-05 17:54:45
1
To see more videos from user @karolinesm, please go to the Tikwm homepage.

Other Videos

Switzerland VS Colombia Today Match Drow full highlights #foryoupage #foryoupage #fifaworldcup
Switzerland VS Colombia Today Match Drow full highlights #foryoupage #foryoupage #fifaworldcup
🕺#cwrloz #chadiriad #intros #jamal
🕺#cwrloz #chadiriad #intros #jamal


A team of scientists from Cleveland, Ohio, and Seoul National University has discovered that an immune system enzyme called 15-PGDH becomes overly active in Parkinson's, destroying protective molecules and causing severe cell-killing inflammation. By testing an oral drug that blocks this enzyme across three different models, the researchers successfully lowered toxic inflammation, kept vital brain cells alive, and restored motor control. Crucially, this treatment protects the brain without needing to clear out alpha-synuclein proteins, meaning it shields neurons even when these characteristic clumps are present. Because a matching drug targeting this exact enzyme has already safely completed Phase 1 human trials for muscle health, researchers have a head start that could significantly accelerate the timeline for bringing this potential treatment to Parkinson's clinical trials. 🚀 Scientists discover that blocking the 15-PGDH enzyme stops the destructive cycle of inflammation and oxidative stress that kills dopamine-producing cells. 🔬 The oral treatment successfully crosses the blood-brain barrier to shield neurons and significantly improve motor function in multiple models. 🛡️ Neurons are protected by disarming the brain's toxic damage response directly, meaning the therapy works even while alpha-synuclein protein clumps remain present. ⏩ Because a similar drug has already safely passed Phase 1 human clinical trials for another condition, researchers have an accelerated path toward future Parkinson's trials. 👉 Read the full story now on Parkinson's Insights @parkinsonsinsights.com Powered by @pdbuddyapp and @nosilverbullet4pd #parkinsonsawareness #parkinsons #parkinson #parkinsonsresearch
A team of scientists from Cleveland, Ohio, and Seoul National University has discovered that an immune system enzyme called 15-PGDH becomes overly active in Parkinson's, destroying protective molecules and causing severe cell-killing inflammation. By testing an oral drug that blocks this enzyme across three different models, the researchers successfully lowered toxic inflammation, kept vital brain cells alive, and restored motor control. Crucially, this treatment protects the brain without needing to clear out alpha-synuclein proteins, meaning it shields neurons even when these characteristic clumps are present. Because a matching drug targeting this exact enzyme has already safely completed Phase 1 human trials for muscle health, researchers have a head start that could significantly accelerate the timeline for bringing this potential treatment to Parkinson's clinical trials. 🚀 Scientists discover that blocking the 15-PGDH enzyme stops the destructive cycle of inflammation and oxidative stress that kills dopamine-producing cells. 🔬 The oral treatment successfully crosses the blood-brain barrier to shield neurons and significantly improve motor function in multiple models. 🛡️ Neurons are protected by disarming the brain's toxic damage response directly, meaning the therapy works even while alpha-synuclein protein clumps remain present. ⏩ Because a similar drug has already safely passed Phase 1 human clinical trials for another condition, researchers have an accelerated path toward future Parkinson's trials. 👉 Read the full story now on Parkinson's Insights @parkinsonsinsights.com Powered by @pdbuddyapp and @nosilverbullet4pd #parkinsonsawareness #parkinsons #parkinson #parkinsonsresearch
@pandacantor @icaroegilmar @ResenhadoCabraloficial @HumbertoeRonaldo #mjmusiccy
@pandacantor @icaroegilmar @ResenhadoCabraloficial @HumbertoeRonaldo #mjmusiccy
Allohimga bixisob Shukur Mani Dunyoyim Qezlarim🥰
Allohimga bixisob Shukur Mani Dunyoyim Qezlarim🥰

About

Legal